Type 2 Diabetes Clinical Trial
Official title:
Group Prenatal Care for Women With Diabetes: A Pilot Randomized Control Trial
Verified date | January 2018 |
Source | Washington University School of Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The investigators primary objective is to conduct a pilot randomized trial to determine the effect of group prenatal care on self-care activities in women with diabetes.
Status | Completed |
Enrollment | 84 |
Est. completion date | September 27, 2017 |
Est. primary completion date | July 6, 2017 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 50 Years |
Eligibility |
Inclusion Criteria: - English (WUMC) or Spanish speaking (DH) - Type 2 White's Class B diabetes OR gestational diabetes diagnosed by 2-step method < 32 weeks - Ability to attend group prenatal visit at specified days and times - Willingness to be randomized - Randomization at 22 weeks 0 days-32 weeks 0 days - Ability to give informed consent Exclusion Criteria: - Multiple gestation - Major fetal anomaly - Serious medical co-morbidity necessitating more care than can be safely provided in group setting, as deemed by medical provider - Serious psychiatric illness including schizophrenia necessitating more care than can safely be provided in group setting, as deemed by medical provider |
Country | Name | City | State |
---|---|---|---|
United States | Denver Health | Denver | Colorado |
United States | Washington University in St. Louis | Saint Louis | Missouri |
Lead Sponsor | Collaborator |
---|---|
Washington University School of Medicine | Denver Health Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | effect of group prenatal care on maternal diabetes self-care activities as measured Diabetes Self-Care Activities Measure | Determine the effect of group prenatal care on maternal diabetes self-care activities as measured by the Diabetes Self-care Activities Measure and confirmed by percentage of recommended blood glucose values completed on logs since initial study visit. | 37-39 weeks gestation | |
Secondary | effect of group prenatal care on perinatal mood as measured by Edinburgh Postnatal Depression Scale | Determine the effect of group prenatal care on perinatal mood as measured by the Edinburgh Postnatal Depression Scale | baseline and 4-12 weeks postpartum | |
Secondary | effect of group prenatal care on perceived social support as assessed by the Social Support Scale | Determine the effect of group prenatal care on perceived social support through the Social Support Scale | 37-39 weeks | |
Secondary | Birthweight | Determine the effect of group prenatal care on birthweight | delivery admission | |
Secondary | Gestational age at delivery | Determine the effect of group prenatal care on preterm delivery | delivery admission | |
Secondary | Mean 3rd trimester fasting blood glucose | Determine the effect of group prenatal care on maternal glycemic control through mean 3rd trimester fasting glucose | baseline through delivery | |
Secondary | Breastfeeding | Determine the effect of group prenatal care on initiating breastfeeding | 4-12 weeks postpartum | |
Secondary | Contraception | Determine the effect of group prenatal care on initiating contraception | 4-12 weeks postpartum |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |